Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (IS) (2016 - 2024)

Historic Depreciation & Amortization (IS) for Select Medical Holdings (SEM) over the last 16 years, with Q3 2024 value amounting to $50.1 million.

  • Select Medical Holdings' Depreciation & Amortization (IS) fell 429.63% to $50.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $212.1 million, marking a year-over-year increase of 247.87%. This contributed to the annual value of $208.7 million for FY2023, which is 141.72% up from last year.
  • Per Select Medical Holdings' latest filing, its Depreciation & Amortization (IS) stood at $50.1 million for Q3 2024, which was down 429.63% from $53.9 million recorded in Q2 2024.
  • In the past 5 years, Select Medical Holdings' Depreciation & Amortization (IS) registered a high of $54.1 million during Q1 2024, and its lowest value of $49.6 million during Q1 2021.
  • Over the past 5 years, Select Medical Holdings' median Depreciation & Amortization (IS) value was $51.5 million (recorded in 2020), while the average stood at $51.6 million.
  • Its Depreciation & Amortization (IS) has fluctuated over the past 5 years, first tumbled by 534.75% in 2020, then skyrocketed by 800.98% in 2024.
  • Over the past 5 years, Select Medical Holdings' Depreciation & Amortization (IS) (Quarter) stood at $51.5 million in 2020, then rose by 0.81% to $51.9 million in 2021, then increased by 0.58% to $52.2 million in 2022, then grew by 3.33% to $54.0 million in 2023, then fell by 7.12% to $50.1 million in 2024.
  • Its Depreciation & Amortization (IS) was $50.1 million in Q3 2024, compared to $53.9 million in Q2 2024 and $54.1 million in Q1 2024.